[1]
Faiza Fatima, “Zongertinib in HER2-Mutant Advanced/Metastatic Solid Tumors: A Narrative Review and Future Prospectives”, J Can Biomol Therap, vol. 3, no. 2, pp. 13–24, Apr. 2026.